Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA ...

On 20 March 2025, the Patent Trial and Appeal Board (PTAB) designated as “Informative” the majority opinion in the Decision ...

Founder Jeremy Zimmer steps back as CEO at age 66, prompting a look at cross-town rivals run by fellow boomers.

In a changing of the guard at one of Hollywood’s biggest talent agencies, UTA says that David Kramer will take over as CEO in ...